Effect of age on recurrence in hormone receptor-positive breast cancer, and factors significantly associated with cancer recurrence
Keywords:
Age; hormone receptor-positive breast cancer; recurrenceAbstract
Objective: Age is an important factor for predicting survival, with worse prognosis among young women compared to middle-aged women. Hormone receptor-positive breast cancer is the most commonly reported diagnoses among younger women. This study aimed to investigate the effect of age on recurrence in hormone receptor-positive breast cancer patients, and to identify its significant related factors.
Methods: Operable hormone receptor-positive breast cancer patients who underwent surgery at the Division of Head, Neck, and Breast Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand during 2008-2013 were retrospectively recruited. Age at diagnosis, follow-up time, staging, tumor characteristics, treatment, and date of recurrence were collected, recorded, and analyzed.
Results: Of the 431 patients that were included, 145 patients were aged 40 years or younger, and 286 patients were aged older than 40 years. The median follow-up time was 4.1 years. In multivariate analysis, the unadjusted recurrence rate was higher in T3-4, node positive, high pathological grade, and lymphovascular invasion. After adjusting for age, only N stage N1 remained statistically significant (hazard ratio [HR]: 2.75, 95% confidence interval [CI]: 1.18-6.40; p=0.19). The recurrence rate was found to be non-significantly higher in younger patients than in older patients (11% vs. 5.6%, p=0.21).
Conclusion: The results of this study revealed no significant difference between age groups for recurrence-free survival in women with hormone receptor-positive breast cancer; however, younger women did demonstrate a higher rate of recurrence. N stage N1 is an independent predictor of cancer recurrence.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following conditions:
Copyright Transfer
In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.
License
Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.
Sharing and Access
Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.